Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.

作者: Matthew L. Banks , Douglas A. Smith , Bruce E. Blough

DOI: 10.1097/FBP.0000000000000224

关键词:

摘要: The dopamine transporter (DAT) inhibitor and nicotinic acetylcholine (nACh) receptor antagonist bupropion is being investigated as a candidate 'agonist' medication for methamphetamine addiction. In addition to its complex pharmacology, also has two distinct pharmacologically active metabolites. However, the mechanism by which produces methamphetamine-like effects remains unknown. aim of present study was determine role DAT inhibition, nACh antagonism, hydroxybupropion metabolites in discriminative stimulus rhesus monkeys. addition, varenicline, partial agonist at receptor, risperidone, antagonist, were tested controls. Monkeys (n=4) trained discriminate 0.18 mg/kg intramuscular from saline two-key food-reinforced discrimination procedure. potency time course determined all compounds. Bupropion, methylphenidate, 2S,3S-hydroxybupropion produced full, least 90%, effects. 2R,3R-Hydroxybupropion, mecamylamine, nicotine full effects, but drug more variable between Varenicline whereas risperidone did not. Overall, these results suggest inhibition major bupropion, although antagonism appeared, partially, contribute. Furthermore, contribution metabolite could not be completely ruled out.

参考文章(37)
J. H. Woods, A. J. Bertalmio, A. M. Young, W. D. Essman, G. Winger, Receptor mechanisms of opioid drug discrimination. Psychopharmacology series. ,vol. 4, pp. 95- 106 ,(1988) , 10.1007/978-3-642-73223-2_8
C. R. Schuster, C. E. Johanson, Relationship between the discriminative stimulus properties and subjective effects of drugs. Psychopharmacology series. ,vol. 4, pp. 161- 175 ,(1988) , 10.1007/978-3-642-73223-2_13
John D. Fryer, Ronald J. Lukas, Noncompetitive Functional Inhibition at Diverse, Human Nicotinic Acetylcholine Receptor Subtypes by Bupropion, Phencyclidine, and Ibogaine Journal of Pharmacology and Experimental Therapeutics. ,vol. 288, pp. 88- 92 ,(1999)
Wen Lin Sun, D. E. McMillan, W. C. Hardwick, Effects of drug discrimination history on the generalization of pentobarbital to other drugs. Journal of Pharmacology and Experimental Therapeutics. ,vol. 278, pp. 50- 61 ,(1996)
W L Woolverton, M S Kleven, E W Anthony, Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics. ,vol. 254, pp. 312- 317 ,(1990)
MATTHEW BRENSILVER, KEITH G. HEINZERLING, AIMEE-NOELLE SWANSON, DONATELLO TELESCA, BENJAMIN A. FURST, STEVEN J. SHOPTAW, Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment Drug and Alcohol Review. ,vol. 32, pp. 96- 99 ,(2013) , 10.1111/J.1465-3362.2012.00423.X
Kelly E. Courtney, Lara A. Ray, Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature Drug and Alcohol Dependence. ,vol. 143, pp. 11- 21 ,(2014) , 10.1016/J.DRUGALCDEP.2014.08.003
Kathleen A Grant, Strategies for Understanding the Pharmacological Effects of Ethanol With Drug Discrimination Procedures Pharmacology Biochemistry and Behavior. ,vol. 64, pp. 261- 267 ,(1999) , 10.1016/S0091-3057(99)00075-1